Section Arrow
LVTX.NASDAQ
- LAVA Therapeutics NV
Quotes are at least 15-min delayed:2025/07/14 17:23 EDT
After Hours
Last
 1.49
+0.01 (+0.68%)
Bid
1.44
Ask
1.49
High 1.49 
Low 1.4 
Volume 2373 
Regular Hours
Last
 1.48
+0.12 (+8.82%)
Day High 
1.4894 
Prev. Close
1.36 
1-M High
1.4 
Volume 
152.26K 
Bid
1.44
Ask
1.49
Day Low
1.38 
Open
1.38 
1-M Low
1.27 
Market Cap 
35.78M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.33 
20-SMA 1.32 
50-SMA 1.3 
52-W High 2.39 
52-W Low 0.8502 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.05/-0.66
Enterprise Value
35.86M
Balance Sheet
Book Value Per Share
0.98
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
11.98M
Operating Revenue Per Share
0.92
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NCNANuCana plc0.0459-0.0043-8.57%-- 
After Hours 0.0475 +0.0016 +3.49%
PMNProMIS Neurosciences0.52+0.129599+33.20%4.34PE
After Hours 0.49 -0.03 -5.77%
WINTWindtree Therapeutics Inc.0.79+0.06+8.22%0.84PE
After Hours 0.7821 -0.0079 -1.00%
DAREDare Bioscience Inc.3.09+0.575+22.86%0.1PE
After Hours 3.19 +0.1 +3.24%
RANIRani Therapeutics Holdings0.6984+0.0544+8.45%-- 
After Hours 0.6293 -0.0691 -9.89%
Quotes are at least 15-min delayed:2025/07/14 17:23 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.